Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial
Related Posts
Hsu YC, Lu M, Llanes A, Keushkerian MJ, Nguyen KL, Johnson K, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner D, McNally[...]
Shiraishi Y, Nakamaru R, Kohsaka S, Sandhu AT, Heidenreich PA, Ikemura N, Sawano M, Niimi N, Kimura T, Katsumata Y, Nishiyama T, Ueda I, Takatsuki[...]
Zhang D, Zhao G, Zhang Y, Xu D, Wang S, Wang K, Zhou B, Ling Y, Liu Y, Cui Q, Yin J, Zhu E, Zhao[...]